Clinical Trial Update: Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metformin in combination with FOLFIRI plus targeted therapy for metastatic colorectal cancer. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Target therapy (unspecified)
• metformin (metformin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Progression-Free Survival | Phase 2 | Status: RECRUITING